At a glance
ClinicalIndex Comparison RecordN/ACompleted· 16 enrolled
Drug / intervention
SECM Skin Imagingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study of Imaging Human Skin With High-Speed Spectrally Encoded Confocal Microscopy
In Brief
A clinical study evaluating SECM Skin Imaging for Pigmented Lesions and 3 related conditions. Completed, enrolled 16 participants across 1 site.
Detailed Summary
The aim of this study is to evaluate the imaging performance of Spectrally Encoded Confocal Microscopy (SECM) for imaging human skin and skin diseases.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPigmented Lesions, Pigmented Skin Lesion, Pigmented Moles, Skin Lesion
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedSep 2020
Enrollment StartJul 2021
Primary CompletionOct 2021
TodayJul 2026
First PostedSep 28, 2020
Enrollment StartJul 19, 2021
Primary CompletionOct 22, 2021
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 5.8 years ago
Interventions
SECM Skin Imagingdevice
Consented Participants will be asked to allow their forearm to be imaged by the dermatoscope on the same skin/lesions as a control comparison. We will be trying to image pigmented skin/lesions present on the forearm. This will be followed by imaging using the SECM Skin imaging device